NASDAQ:PRVA
Privia Health Group, Inc.
- Stock
Last Close
23.98
06/11 21:01
Market Cap
2.04B
Beta: 0.77
Volume Today
704.96K
Avg: 1.00M
PE Ratio
60.20
PFCF: 50.24
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | ||||||
average payables | 2.88M - | 4.10M 42.50% | 4.85M 18.23% | 195.32M 3,925.56% | |||
average receivables | 88.23M - | 108.26M 22.70% | 153.50M 41.79% | 240.19M 56.47% | |||
book value per share | 1.07 - | 1.43 33.15% | 4.15 190.42% | 4.86 17.11% | 4.50 7.27% | ||
capex per share | -0.00 - | -0.06 2,495% | -0.00 93.34% | -0.01 43.71% | -0.00 80.96% | -0.00 10.43% | |
capex to depreciation | -0.21 - | -4.00 1,849.43% | -0.21 94.81% | -0.22 6.91% | -0.02 89.75% | -0.02 23.98% | |
capex to operating cash flow | -0.04 - | -0.23 459.21% | -0.01 95.83% | -0.01 1.68% | -0.00 77.82% | -0.00 38.95% | |
capex to revenue | -0.00 - | -0.01 2,070.12% | -0.00 93.59% | -0.00 21.73% | -0.00 86.46% | -0.00 11.08% | |
cash per share | 0.46 - | 0.82 80.50% | 3.11 278.17% | 3.39 8.73% | 3.12 7.73% | ||
days of inventory on hand | |||||||
days payables outstanding | 0.27 - | 2.60 874.60% | 1.20 53.78% | 2.01 67.24% | 93.25 4,537.50% | ||
days sales outstanding | 35.90 - | 44.28 23.34% | 44.35 0.16% | 51.01 15.02% | 64.02 25.50% | ||
debt to assets | 0.16 - | 0.10 35.86% | 0.07 33.79% | 0.01 78.58% | 0.01 42.86% | ||
debt to equity | 0.39 - | 0.23 41.35% | 0.11 52.51% | 0.02 78.84% | 0.01 35.94% | ||
dividend yield | |||||||
earnings yield | -0.00 - | 0.00 370.83% | 0.01 278.99% | -0.07 641.62% | -0.01 92.78% | 0.01 255.51% | |
enterprise value | 2.36B - | 2.31B 2.00% | 2.39B 3.29% | 2.00B 16.39% | 2.49B 24.65% | ||
enterprise value over ebitda | 134.96 - | 84.97 37.04% | -11.11 113.08% | -137.29 1,135.28% | 91.62 166.73% | ||
ev to operating cash flow | 96.90 - | 59.48 38.62% | 43.40 27.04% | 42.33 2.46% | 29.65 29.96% | ||
ev to sales | 3.00 - | 2.83 5.68% | 2.47 12.65% | 1.47 40.45% | 1.50 2.01% | ||
free cash flow per share | 0.05 - | 0.18 270.83% | 0.37 106.50% | 0.53 41.32% | 0.46 13.47% | 0.67 46.84% | |
free cash flow yield | 0.00 - | 0.01 270.83% | 0.02 106.50% | 0.02 25.64% | 0.02 1.43% | 0.03 44.80% | |
graham net net | -0.56 - | -0.26 54.46% | 1.67 753.46% | 2.11 25.72% | 1.72 18.08% | ||
graham number | 1.39 - | 3.12 124.64% | 13.14 320.62% | 3.58 72.76% | 4.33 20.93% | ||
income quality | -1.25 - | 3.07 344.67% | 1.26 58.95% | -0.29 122.95% | -3.91 1,254.65% | 3.64 193.03% | |
intangibles to total assets | 0 - | 0.46 Infinity% | 0.38 18.28% | 0.27 27.83% | 0.23 14.97% | 0.25 5.98% | |
interest coverage | 0.34 - | 2.32 592.48% | 13.24 469.57% | -203.21 1,634.89% | -35.28 82.64% | -2.47 93.01% | |
interest debt per share | 0.49 - | 0.35 28.86% | 0.46 33.49% | 0.12 74.64% | -0.00 100.57% | ||
inventory turnover | |||||||
invested capital | 0.39 - | 0.23 41.35% | 0.11 52.51% | 0.02 78.84% | 0.01 35.94% | ||
market cap | 2.36B - | 2.36B 0% | 2.36B 0% | 2.66B 12.66% | 2.33B 12.36% | 2.87B 23.02% | |
net current asset value | -33.15M - | 4.77M 114.38% | 210.48M 4,315.44% | 278.20M 32.17% | 308.29M 10.82% | ||
net debt to ebitda | -0.22 - | -1.87 764.28% | 1.27 168.09% | 23.12 1,713.78% | -14.02 160.65% | ||
net income per share | -0.03 - | 0.08 370.83% | 0.30 278.99% | -1.85 709.21% | -0.12 93.66% | 0.19 257.70% | |
operating cash flow per share | 0.05 - | 0.24 364.05% | 0.38 59.66% | 0.53 41.34% | 0.46 14.14% | 0.67 46.72% | |
payables turnover | 1.37K - | 140.30 89.74% | 303.58 116.38% | 181.53 40.20% | 3.91 97.84% | ||
receivables turnover | 10.17 - | 8.24 18.93% | 8.23 0.16% | 7.16 13.06% | 5.70 20.32% | ||
research and ddevelopement to revenue | |||||||
return on tangible assets | 0.06 - | 0.15 168.80% | -0.38 350.01% | -0.02 94.81% | 0.03 254.48% | ||
revenue per share | 6.40 - | 7.65 19.58% | 7.95 3.91% | 9.39 18.06% | 13.20 40.64% | 13.30 0.73% | |
roe | 0.07 - | 0.21 184.63% | -0.45 309.77% | -0.02 94.59% | 0.04 270.06% | ||
roic | 0.09 - | 0.19 103.74% | -0.39 310.10% | -0.02 93.89% | 0.03 209.42% | ||
sales general and administrative to revenue | 0.06 - | 0.05 15.71% | 0.05 1.28% | 0.26 391.61% | 0.10 63.93% | 0.07 30.80% | |
shareholders equity per share | 1.07 - | 1.43 33.15% | 4.15 190.42% | 4.86 17.11% | 4.50 7.27% | ||
stock based compensation to revenue | 0.00 - | 0.00 91.08% | 0.00 125.03% | 0.26 44,196.72% | 0.05 81.08% | 0.02 54.93% | |
tangible asset value | -17.83M - | 19.01M 206.62% | 262.50M 1,280.95% | 334.72M 27.51% | 361.01M 7.85% | ||
tangible book value per share | -0.17 - | 0.18 206.62% | 2.55 1,278.72% | 3.26 27.72% | 2.90 11.09% | ||
working capital | 14.38M - | 43.15M 200.06% | 256.21M 493.83% | 287.69M 12.28% | 313.85M 9.09% |
All numbers in USD (except ratios and percentages)